Rs 2,300 profit per share? Brokerage sees up to 33% gain after Q3 results in this healthcare stock

Apollo Hospitals reported a 35 per cent rise in consolidated profit after tax (PAT) to Rs 502 crore for the quarter ended December, driven by strong performance across its healthcare businesses. The company had posted a PAT of Rs 372 crore in the same period last year.

Revenue for the quarter increased to Rs 6,477 crore, up 17 per cent from Rs 5,527 crore a year ago. The healthcare services division recorded revenue of Rs 3,183 crore, a 14 per cent increase.

Apollo Health and Lifestyle posted Rs 467 crore in revenue, up 20 per cent, while Apollo Health reported Rs 2,827 crore, also up 20 per cent year-on-year.

Add Zee Business as a Preferred Source

Apollo Hospitals Dividend

The board of Apollo Hospitals has declared an interim dividend of Rs 10 per share for the financial year 2025-26. The dividend record date is February 16, 2026. The company had paid Rs 10 per share in the previous interim dividend in August 2025 and Rs 9 per share in February 2025.

Apollo Hospitals Share Price Target

Analysts remained positive on the stock. Citi maintained a “Buy” rating with a target of Rs 9,600, suggesting a potential upside of Rs 2,380 per share, or 33 per cent from current levels.

Morgan Stanley retained an “Overweight” rating with a target of Rs 8,813, indicating a potential gain of Rs 1,593 per share, or 22 per cent.

Citi highlighted strong performance in the hospitals segment, which grew 15 per cent, with EBITDA margins improving 0.6 percentage points to 24.5 per cent despite the addition of greenfield capacities.

Health business performance also improved, with a 12 per cent reduction in 24/7 costs, leading to a 2.1 percentage-point margin expansion.

Morgan Stanley said consolidated revenue of Rs 6,477 crore was in line with estimates, led by 14 per cent growth in hospitals and 20 per cent growth in pharmacy. EBITDA rose 27 per cent to Rs 967 crore, 2.4 per cent above estimates. PAT was Rs 502 crore, 6 per cent above expectations, including one-time costs of Rs 19.2 crore related to labour wage code changes.

Apollo Hospitals Share Price Today

Shares of Apollo Hospitals were trading 4.26 per cent higher at Rs 7,535.25 on the BSE on Wednesday in early trade.

The stock has gained 4.44 per cent in one week, 8.90 per cent in two weeks, and 1.93 per cent in one month. Over six months, it rose 4.47 per cent, 15.04 per cent in two years, 67.52 per cent in three years, and 168.60 per cent in five years.

The 52-week high and low were Rs 8,099 and Rs 6,002, respectively. The company has a market capitalisation of Rs 1,06,400.65 crore and is part of the BSE 100 index in the hospital industry.

Apollo Hospitals Q3 Update

Apollo Hospitals’ EBITDA for the quarter rose 27 per cent to Rs 965 crore, with margins improving 1.12 percentage points to 14.9 per cent, even after absorbing Rs 124 crore in Apollo 24/7 costs, including a Rs 38 crore non-cash ESOP charge.

On a year-to-date basis, revenue for the nine months grew 15 per cent to Rs 18,623 crore, while PAT increased 34 per cent to Rs 1,412 crore, reflecting strong operating leverage across the network.

The core healthcare services (hospitals) segment reported a 14 per cent rise in revenue to Rs 3,183 crore, with EBITDA up 18 per cent to Rs 790 crore and margins steady at 24.8 per cent.

Overall occupancy stood at 67 per cent, with revenue growth across key regions: Tamil Nadu 14 per cent, AP/Telangana 16 per cent, Karnataka 16 per cent, Eastern region 15 per cent, Western region 17 per cent, and Northern region 12 per cent.